Bryan Stuart is Director of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 0 shares of FULC, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2021, when has been sold 28,000 shares (Common Stock) at a price of $23.75 per share, resulting in proceeds of $665,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Bryan Stuart Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2021
SELL
Open market or private sale
$665,000 $23.75 p/Share
28,000 Reduced 100.0%
0 Common Stock
Aug 11 2021
BUY
Exercise of conversion of derivative security
$219,520 $7.84 p/Share
28,000 Added 50.0%
28,000 Common Stock
Aug 10 2021
SELL
Open market or private sale
$560,000 $17.5 p/Share
32,000 Reduced 100.0%
0 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
$250,880 $7.84 p/Share
32,000 Added 50.0%
32,000 Common Stock
BS

Bryan Stuart

Director
Cambridge, MA

Track Institutional and Insider Activities on FULC

Follow Fulcrum Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FULC shares.

Notify only if

Insider Trading

Get notified when an Fulcrum Therapeutics, Inc. insider buys or sells FULC shares.

Notify only if

News

Receive news related to Fulcrum Therapeutics, Inc.

Track Activities on FULC